Can I speak with someone from your office immediately?
Yes – please call now and we will be more than happy to speak with you. If we are on another call we will call you back immediately.
How should I begin a conversation with your practice?
A phone call is a great way to start. If you want to provide us with detailed information about your situation use our form on this page to share that information. All information is kept strictly confidential.
Is it ever too late to reach out to you (do you treat late state cancers)?
Our care is unique and forward-thinking. Please reach out. It may not be too late to alter the course of your cancer.
Can I schedule a video consultation (instead of an in-person meeting)?
We are more than happy to do a video conference with you from the comfort of your own home.
Does insurance cover your oncology treatments?
Coverage varies by insurance plan, but our team has extensive experience working with major insurers and securing approvals — even for complex or innovative treatments. We handle the process efficiently to help patients focus on what matters most: their care.
What types of cancer to you treat?
Our focus is on the following cancers: Pancreatic. Ovarian, Colo, and Bile Duct cancers. However if you have a different type of cancer call us anyways. We can refer you to the appropriate physican.
Are there another practices that do what Hirschfeld Oncology does?
There is no practice like ours. Some oncologists offer variations on traditional therapy, like we do, however there is no practice that offers the level of innovation that we do at Hirschfeld Oncology.
Low-Dose Multi-Drug Combinations
By combining 4–6 chemotherapy drugs at lower doses, Dr. Hirschfeld reduces side effects while maximizing the synergy between medicines to fight cancers more effectively.
Repurposed Medicines
Well-established drugs from other medical fields are safely adapted to oncology, opening new treatment paths for patients who have already exhausted standard options.
Genomic profiling
Each tumor’s unique genetic profile is analyzed, allowing therapies to be precisely matched to the cancer’s biology for greater accuracy and impact.
Data-Driven Off-Label Use
When evidence strongly supports benefit, FDA-approved drugs are used off-label, giving patients earlier access to promising treatments beyond standard protocols.